日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Accuracy and Acceptability of the VISITECT CD4 Advanced Disease Test Compared With the PIMA CD4 Test at the Point of Care as Part of the Advanced HIV Disease Care Package: A Mixed-Methods Study

VISITECT CD4 晚期疾病检测与 PIMA CD4 检测在即时检测中作为晚期 HIV 疾病护理方案一部分的准确性和可接受性比较:一项混合方法研究

Gils, T; Misra, S; Madonsela, T; Pita, T P; Bosman, S; Ayakaka, I; Vlieghe, E; van Heerden, A; Lynen, L; Decroo, T; Reither, K

Pre-extensively drug-resistant tuberculosis of the spine in a previously healthy young adult: case report

既往健康青年发生广泛耐药性脊柱结核:病例报告

Schreurs, Hanne; Dejaegher, Joost; Decroo, Tom; André, Emmanuel; Lorent, Natalie; Henckaerts, Liesbet

Sustained outcomes 3 years after all-oral 9-month regimen for rifampicin-resistant TB

利福平耐药结核病患者接受全口服9个月疗程后3年仍保持疗效

Nguyen, T M P; Le, T H M; Merle, C S C; Guglielmetti, L; Nguyen, N L; Dinh, V L; Nguyen, B H; Hoang, T T T; Nguyen, V N; Callens, S; Decroo, T

Paucibacillary Tuberculosis Drives the Low Positive Predictive Value of Xpert MTB/RIF Ultra for Rifampicin Resistance Detection in Low-Prevalence Settings

在低流行率地区,少菌型结核病导致 Xpert MTB/RIF Ultra 检测利福平耐药性的阳性预测值较低。

Cuella-Martin, Isabel; Hakizayezu, Francois; Ahmed, Aymen; Runyambo, Docteur; Niyompano, Hosee; Keysers, Jelle; De Rijk, Willem Bram; Mulders, Wim; Mitchell, Ellen M H; Decroo, Tom; Habimana, Yves Mucyo; Migambi, Patrick; Muvunyi, Claude Mambo; de Jong, Bouke C; Rigouts, Leen; Ngabonziza, Jean Claude Semuto

Pretreatment attrition after rifampicin-resistant tuberculosis diagnosis with Xpert MTB/RIF or ultra in high TB burden countries: a systematic review and meta-analysis

在结核病高负担国家,使用 Xpert MTB/RIF 或 ultra 检测利福平耐药结核病后,治疗前患者流失情况:系统评价和荟萃分析

Jouego, Christelle Geneviève; Decroo, Tom; Netongo, Palmer Masumbe; Gils, Tinne

Phenotypic and genotypic resistance to bedaquiline in patients with multi-drug-resistant tuberculosis-experiences from Armenia

亚美尼亚的经验表明,多重耐药结核病患者对贝达喹啉的表型和基因型耐药性

Ardizzoni, E; Mulders, W; De Diego Fuertes, M; Hayrapetyan, A; Mirzoyan, A; Faqirzai, J; Khachatryan, N; Oganezova, I; Varaine, F; Bastard, M; Graulus, P; Meehan, C J; Rigouts, L; de Jong, B C; Decroo, T; Hewison, C; Van Rie, A

Uptake and challenges with daily oral pre-exposure prophylaxis among men who have sex with men and transgender women, suburban Yangon, Myanmar

缅甸仰光郊区男男性行为者和跨性别女性每日口服暴露前预防药物的接受度和挑战

Tun, Ni Ni; Smithuis, Frank; Tun, Nyan Lynn; Hteik, Myo Min Min; Ko, Myat Ko; Lynen, Lutgarde; Decroo, Tom; Florence, Eric; Gils, Tinne

Estimation of therapeutic threshold for tuberculosis using adapted nominal group technique and clinical vignettes in clinical and community settings in Southern Africa

在南部非洲的临床和社区环境中,利用改进的名义小组技术和临床案例估算结核病的治疗阈值

Keter, Alfred Kipyegon; Heerden, Alastair Van; Decroo, Tom; Boyles, Tom; Bosman, Shannon; Madonsela, Thandanani; Msimango, Lindani Innocent; Naiken, Lenika; Kiyan, Carlos; Kamele, Mashaete; Ayakaka, Irene; Reither, Klaus; Mario Jacobs, Bart Karl; Lynen, Lutgarde

High-dose amikacin in the first week of all-oral rifampicin-resistant TB treatment is safe: a single-arm trial

在全口服利福平耐药结核病治疗的第一周使用高剂量阿米卡星是安全的:一项单臂试验

Snobre, J; Gasana, J; Decroo, T; Mucyo, Y; Jacobs, B K M; Rigouts, L; Martin, I C; Herssens, N; Hakizayezu, F; Ntihumbya, J B; Kilibazayire, A; de Viron, E; Runyambo, D; Ndayishimiye, C; Merle, C S; Muvunyi, C M; Migambi, P; Sturkenboom, M G G; de Jong, B C; Ngabonziza, J C S

Underutilisation of GeneXpert devices for TB diagnosis: a missed opportunity

GeneXpert设备在结核病诊断中的应用不足:错失良机

Dörfler, J; Ravololohanitra, O G; Decroo, T; Franke, M A; Emmrich, J; Pasteur, G I; Harizaka, E A; Muller, N